Product NDC: | 0145-5371 |
Proprietary Name: | DUAC |
Non Proprietary Name: | clindamycin phosphate and benzoyl peroxide |
Active Ingredient(s): | 50; 10 mg/g; mg/g & nbsp; clindamycin phosphate and benzoyl peroxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0145-5371 |
Labeler Name: | Stiefel Laboratories Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050741 |
Marketing Category: | NDA |
Start Marketing Date: | 20110301 |
Package NDC: | 0145-5371-61 |
Package Description: | 20 TUBE in 1 CARTON (0145-5371-61) > 5 g in 1 TUBE (0145-5371-01) |
NDC Code | 0145-5371-61 |
Proprietary Name | DUAC |
Package Description | 20 TUBE in 1 CARTON (0145-5371-61) > 5 g in 1 TUBE (0145-5371-01) |
Product NDC | 0145-5371 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | clindamycin phosphate and benzoyl peroxide |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20110301 |
Marketing Category Name | NDA |
Labeler Name | Stiefel Laboratories Inc |
Substance Name | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
Strength Number | 50; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |